jvrs-100
Gene therapyexperimental
Clinical trial activity
7 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2008 (NCT00662272)
Timeline
Indications
Mechanism of action
- UnclearImmunity, active
Unclear immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- jvrs-100
- jvs-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02544204 | Phase 2 | Nov 1, 2015 | Juventas Therapeutics, Inc. |
| NCT01961726 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2013 | Juventas Therapeutics, Inc. |
| NCT01643590 | Phase 2 | Jul 1, 2012 | Juventas Therapeutics, Inc. |
| NCT01657045 | Phase 1 | Jul 1, 2012 | SironRX Therapeutics, Inc., University of Utah, Yeshiva University |
| NCT01410331 | Phase 2 | Mar 1, 2012 | Juventas Therapeutics, Inc., Northwestern University |
| NCT00860522 | Phase 1 | Mar 1, 2009 | Pennsylvania State University |
| NCT00662272 | Phase 1 | Jun 1, 2008 | Colby Pharmaceutical Company, Juvaris BioTherapeutics |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Juventas Therapeutics, Inc. | For profit | 4 | 4 | 1 | 2012 |
| Colby Pharmaceutical Company | For profit | 1 | 1 | 1 | 2008 |
| Juvaris BioTherapeutics | For profit | 1 | 0 | 1 | 2008 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Pennsylvania State University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| SironRX Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2012 |
| University of Utah | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 2012 |
8 organizations
Page 1 / 1